University of Miami Researchers to Present 91 Poster Presentations at ASH 2026 Congress
Researchers from Sylvester Comprehensive Cancer Center and the University of Miami Miller School of Medicine contributed to the preparation of 91 poster presentations that will be featured at this year’s congress of the American Society of Hematology (ASH), one of the world’s leading gatherings dedicated to blood disorders. The congress will take place December 12–15 in New Orleans.
ASH held its first official meeting in April 1958 in Atlantic City, where more than 300 hematologists gathered to discuss clinical and scientific issues related to blood disorders. Over the decades, the society has become one of the leading drivers of progress in hematology. Today, its annual meeting serves as a major international forum for presenting research and exchanging expertise, while Blood, the journal published by ASH, is one of the most highly cited scientific publications in the field.
This year’s poster presentations by Miami researchers cover five areas: multiple myeloma, leukemia, lymphoma, transplantation and cellular therapy, as well as other hematology-related topics. The research explores various aspects of diagnosis, disease monitoring, and the development of new therapeutic approaches.

A significant portion of the presentations focuses on multiple myeloma, a malignancy affecting plasma cells in the bone marrow. Topics include new drug combinations, the use of advanced antibodies, and methods for detecting and monitoring residual cancer cells following treatment. Additional attention is given to patients whose disease has relapsed or failed to respond to previous therapies. In the area of leukemia, researchers are exploring new therapeutic approaches, particularly for acute myeloid leukemia. Topics include drug combinations, targeted therapies, and treatment options for patients who have not achieved the expected results with existing approaches.
Transplantation and cellular therapy also feature prominently. Researchers are investigating ways to improve stem cell transplant outcomes, reduce complications, and advance CAR T-cell therapy. Among the researchers whose work will be presented is Dr. Mikkael A. Sekeres, along with other University of Miami experts.
ASH has also provided free registration for representatives of nonprofit organizations involved in patient advocacy and support. Participation, with 91 poster presentations, represents a significant presence for the University of Miami at one of the world’s largest international hematology gatherings. It is important to note that some of the topics are still in the research or clinical trial stages.
Image: Covaris.com

